Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and ...
Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...
The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes ...
Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...
The Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network for Standards) is pleased to announce formal establishment of its first Governing Board, appointment ...
Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Ngenla Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Ngenla ...
Vietnam is revising its priority high-tech portfolio to better align with global innovation trends and evolving development ...
Gene therapy offers significant opportunities globally due to its potential in treating genetic disorders. Current strategies involve modified viral vectors for gene delivery, with applications in ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
The Hong Kong Productivity Council launched a dedicated facility for research and development in healthcare and lifestyle ...
David Baltimore (March 7, 1938 – September 6, 2025) was an American biologist, university administrator, and 1975 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results